More Obesity Setbacks For Amylin And Takeda

A Phase II trial for their Symlin-based combination therapy was halted after safety issues cropped up with patients from a previous study.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet